Development of a New Focal Mouse Model of Bone Metastasis in Renal Cell Carcinoma

Keita Oya,Hiroyuki Tsuchie,Hiroyuki Nagasawa,Michio Hongo,Yuji Kasukawa,Daisuke Kudo,Ryo Shoji,Fumihito Kasama,Takashi Kawaragi,Manabu Watanabe,Kenta Tominaga,Naohisa Miyakoshi,KEITA OYA,HIROYUKI TSUCHIE,HIROYUKI NAGASAWA,MICHIO HONGO,YUJI KASUKAWA,DAISUKE KUDO,RYO SHOJI,FUMIHITO KASAMA,TAKASHI KAWARAGI,MANABU WATANABE,KENTA TOMINAGA,NAOHISA MIYAKOSHI
DOI: https://doi.org/10.21873/invivo.13541
2024-01-01
In Vivo
Abstract:BACKGROUND/AIM: Developing animal models of bone metastasis in renal cell carcinoma (RCC) is challenging as immunodeficient mice are required. The aim of this study was to develop a simple immune model of RCC bone metastasis.MATERIALS AND METHODS: RENCA tumor cells were injected into the right femurs of BALB/c mice. Sixty mice were grouped into each twenty-mouse group according to the tumor cell concentration, and the presence or absence and extent of bone metastasis in the total length of the femur were compared using hematoxylin and eosin staining of the excised tissues.RESULTS: Bone metastasis was significantly higher in the high concentration group than in the other groups (p<0.05), with 10 mice developing bone metastasis at two weeks and nine mice developing bone metastasis at three weeks. The extent of bone metastasis was significantly greater in the high concentration group than in the other groups (p<0.05). Multiple logistic regression analysis was performed to examine the factors influencing bone metastasis, and only the high concentration was a significant factor (p<0.05).CONCLUSION: We developed a normal immunity mouse model of local bone metastasis from RCC. This model could prove valuable for research into the treatment of bone metastases in RCC.
medicine, research & experimental
What problem does this paper attempt to address?